As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Tuesday, Accelerate Diagnostics' Director, John Patience, made a $314,000 purchase of AXDX, buying 200,000 shares at a cost of $1.57 each. So far Patience is in the green, up about 16.6% on their buy based on today's trading high of $1.83. Accelerate Diagnostics is trading up about 14.7% on the day Wednesday.
And also on Tuesday, Chief Executive Officer Richard Christopher bought $118,392 worth of Lexaria Bioscience, buying 50,000 shares at a cost of $2.37 each. This buy marks the first one filed by Christopher in the past twelve months. Lexaria Bioscience is trading up about 0.7% on the day Wednesday. So far Christopher is in the green, up about 20.4% on their buy based on today's trading high of $2.85.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.